FDA | Biologics Effectiveness and Safety (BEST)

Engaging Stakeholders

The BEST Initiative encourages engagement and interaction among its diverse collaborators and provides opportunities for such partnerships. It also seeks further collaboration with multidisciplinary scientific groups within and outside the government sector ranging from the pharmacoepidemiology to medical informatics and clinical communities to advance development and implementation of new methods and technology for the surveillance of biologics.